Brazil's ANVISA to Reevaluate Ban on E-Cigarettes in 2022

Dec.01.2023
Brazil's ANVISA to Reevaluate Ban on E-Cigarettes in 2022
Brazilian health authorities are set to reconsider the ban on e-cigarettes, despite their widespread illegal presence in the market.

According to a recent report by Veja, the Brazilian National Health Surveillance Agency (ANVISA) is set to hold a public meeting on December 1, 2022 to discuss the ban on e-cigarettes that has been in effect since 2009. Despite the ban, e-cigarettes continue to be widely available in the market in Brazil. A survey conducted by Ipec in 2022 revealed that approximately 2.2 million adults in Brazil regularly consume e-cigarettes, making this market entirely illegal.


Brazilian Senator Soraya Thronicke introduced a bill in October aimed at regulating the production, import, export, sale, supervision, and advertising of e-cigarettes in Brazil. During the defense debate, she emphasized that the sale of e-cigarettes (vapes) in Brazil is currently unregulated, putting consumers at risk as they are unaware of the products or substances they are inhaling. "What risks are these people facing? Why are we indifferent to this serious issue, while consumption has already reached nearly six million adults?" she questioned.


Senator Tronik also cited the losses resulting from tax evasion. "From an economic perspective, the import and sale of e-cigarettes operate on the fringes of the tax system, leading to significant tax losses," she emphasized. According to a study by the Minas Gerais State Industry Federation (FIEMG), the potential market for e-cigarettes could reach 7.5 billion Brazilian reals annually. Considering only imports, the average annual federal tax revenue could reach 2.2 billion Brazilian reals.


Dr. Joelmir Silva, a full-time professor at the Olynda Medical School, emphasized the importance of regulations, stating, "Without regulations, it is impossible to know what is being sold. The lack of control over products, especially those containing counterfeit substances, can pose a greater risk to health. The lack of regulations regarding product composition and ingredient limits is another issue of concern.


Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.